Success Metrics

Clinical Success Rate
87.4%

Based on 90 completed trials

Completion Rate
87%(90/103)
Active Trials
31(15%)
Results Posted
24%(22 trials)
Terminated
13(6%)

Phase Distribution

Ph phase_3
9
4%
Ph not_applicable
115
55%
Ph phase_2
35
17%
Ph phase_4
9
4%
Ph phase_1
5
2%
Ph early_phase_1
1
0%

Phase Distribution

6

Early Stage

35

Mid Stage

18

Late Stage

Phase Distribution174 total trials
Early Phase 1First-in-human
1(0.6%)
Phase 1Safety & dosage
5(2.9%)
Phase 2Efficacy & side effects
35(20.1%)
Phase 3Large-scale testing
9(5.2%)
Phase 4Post-market surveillance
9(5.2%)
N/ANon-phased studies
115(66.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.1%

90 of 111 finished

Non-Completion Rate

18.9%

21 ended early

Currently Active

31

trials recruiting

Total Trials

209

all time

Status Distribution
Active(41)
Completed(90)
Terminated(21)
Other(57)

Detailed Status

Completed90
unknown55
Recruiting20
Terminated13
Active, not recruiting11
Not yet recruiting10

Development Timeline

Analytics

Development Status

Total Trials
209
Active
31
Success Rate
87.4%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (0.6%)
Phase 15 (2.9%)
Phase 235 (20.1%)
Phase 39 (5.2%)
Phase 49 (5.2%)
N/A115 (66.1%)

Trials by Status

suspended21%
withdrawn84%
not_yet_recruiting105%
active_not_recruiting115%
recruiting2010%
terminated136%
unknown5526%
completed9043%

Recent Activity

Clinical Trials (209)

Showing 20 of 209 trialsScroll for more
NCT02756754Not Applicable

Radiofrequency Ablation for Aldosterone-producting Adenoma in Patients With Primary Aldosteronism

Completed
NCT04673032

Radiofrequency (RF) Ablation Prospective Outcomes Study

Completed
NCT05666271

Radiofrequency Ablation for Hepatocellular Carcinoma Using Octopus MP Electrodes

Active Not Recruiting
NCT06732388Phase 2

Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus

Not Yet Recruiting
NCT06170736Not Applicable

Radiofrequency Ablation vs Doppler-guided Haemorrhoidal Artery Ligation in the Treatment of Haemorrhoidal Disease

Recruiting
NCT06553625

Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS

Recruiting
NCT06863181Not Applicable

Comparison of Conventional and Cooled Radiofrequency Ablation in Knee Osteoarthritis

Completed
NCT06134752Not Applicable

Electroporation for Treatment of Atrial Fibrillation

Active Not Recruiting
NCT05952518Not Applicable

PNS vs RFA for Facet Joint Pain

Suspended
NCT05473663Not Applicable

Radiofrequency Ablation After Total Knee Arthroplasty

Active Not Recruiting
NCT02437071Phase 2

Assess the Efficacy of Pembrolizumab Plus Radiotherapy or Ablation in Metastatic Colorectal Cancer Patients

Completed
NCT01153035Not Applicable

Excision Followed by Radiofrequency Ablation for Breast Cancer

Active Not Recruiting
NCT03643224Not Applicable

DiamondTemp™ System for the Treatment of Persistent Atrial Fibrillation

Completed
NCT02558504Phase 4

Radiofrequency in the Treatment of Barrett's Oesophagus

Completed
NCT00712712Phase 2

Morphine After Radiofrequency Ablation of Painful Bone Metastases in Patients With Cancer

Completed
NCT03525366

Prospective Evaluation Of Outcomes For Patients Undergoing Radiofrequency Ablation (RFA) Using HALO Ultra Device For Gastric Antral Vascular Ectasia (GAVE)

Withdrawn
NCT07095803Phase 2

Ivonescimab (PD-1/VEGF Bispecific Antibody) Plus Radiofrequency Ablation for Multiple Advanced Tumors After PD-1 Therapy Failure

Not Yet Recruiting
NCT05142904Phase 3

Radiofrequency Ablation Versus I-131 for Solitary Autonomous Thyroid Nodules

Terminated
NCT03437733Not Applicable

Multi-electrode Radiofrequency Balloon Catheter Use for the Isolation of the Pulmonary Veins.

Completed
NCT04671641Not Applicable

Endovenous Radiofrequency Ablation Closure System in the Treatment of Varicose Veins

Completed

Drug Details

Intervention Type
DEVICE
Total Trials
209